{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(1)"],"submitter":["Shimoda TM"],"pubmed_abstract":["<h4>Background</h4>Evidence is limited as to whether outcomes differ between patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge repair (T-TEER) versus surgical tricuspid valve repair. We aimed to compare outcomes between these 2 approaches.<h4>Methods</h4>We analyzed the data on Medicare fee-for-service beneficiaries aged 65 to 99 years with TR who underwent T-TEER or isolated surgical repair between July 2016 and December 2020. The primary outcome was 2-year all-cause mortality. Other outcomes included in-hospital mortality and permanent pacemaker implantation as well as 2-year heart failure hospitalization and tricuspid valve reintervention. A propensity score matching weight analysis was used to adjust for potential confounders.<h4>Results</h4>A"],"journal":["Circulation. Cardiovascular interventions"],"pagination":["e014825"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11748907"],"repository":["biostudies-literature"],"pubmed_title":["Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results."],"pmcid":["PMC11748907"],"pubmed_authors":["Kuno T","Takayama H","Elmariah S","Latib A","Watanabe A","Gotanda H","Kaneko T","Shimoda TM","Tsugawa Y","Kolte D","Ueyama HA","Miyamoto Y","Zajarias A"],"additional_accession":[]},"is_claimable":false,"name":"Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results.","description":"<h4>Background</h4>Evidence is limited as to whether outcomes differ between patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge repair (T-TEER) versus surgical tricuspid valve repair. We aimed to compare outcomes between these 2 approaches.<h4>Methods</h4>We analyzed the data on Medicare fee-for-service beneficiaries aged 65 to 99 years with TR who underwent T-TEER or isolated surgical repair between July 2016 and December 2020. The primary outcome was 2-year all-cause mortality. Other outcomes included in-hospital mortality and permanent pacemaker implantation as well as 2-year heart failure hospitalization and tricuspid valve reintervention. A propensity score matching weight analysis was used to adjust for potential confounders.<h4>Results</h4>A","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-03T23:36:48.526Z","creation":"2025-04-03T23:36:48.526Z"},"accession":"S-EPMC11748907","cross_references":{"pubmed":["39556351"],"doi":["10.1161/circinterventions.124.014825","10.1161/CIRCINTERVENTIONS.124.014825"]}}